Form 4 for DGX Quest Diagnostics
Accepted 2024-08-29 00:00:00 ET · period of report 2024-08-28 · accession 0001022079-24-000174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-29 | 2024-08-28 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S - Sale | $153.26 | -1,990 | 11.5K | -15% | -$305.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-28 | S | D | 1,990 | $153.26 | 11,459 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $153.2557 to $153.310. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. |